Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.790
+0.070 (1.48%)
Aug 14, 2025, 1:58 PM - Market open
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $258.65 million as of August 14, 2025. Its market cap has decreased by -37.39% in one year.
Market Cap
258.65M
Enterprise Value
131.97M
1-Year Change
-37.39%
Ranking
Category
Stock Price
$4.79
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $258.65M, a decrease of -4.68%. That is a compound annual growth rate of -2.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 254.87M | 17.10% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |